Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Equity: 2009-2024

Historic Return on Equity for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to -0.32%.

  • Ironwood Pharmaceuticals' Return on Equity fell 118.00% to -0.46% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.46%, marking a year-over-year decrease of 118.00%. This contributed to the annual value of -0.32% for FY2024, which is 790.00% up from last year.
  • As of FY2024, Ironwood Pharmaceuticals' Return on Equity stood at -0.32%, which was up 96.14% from -8.22% recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Return on Equity ranged from a high of 1.58% in FY2021 and a low of -8.22% during FY2023.
  • For the 3-year period, Ironwood Pharmaceuticals' Return on Equity averaged around -2.75%, with its median value being -0.32% (2024).
  • In the last 5 years, Ironwood Pharmaceuticals' Return on Equity spiked by 852bps in 2021 and then tumbled by 850bps in 2023.
  • Over the past 5 years, Ironwood Pharmaceuticals' Return on Equity (Yearly) stood at -6.94% in 2020, then soared by 852bps to 1.58% in 2021, then crashed by 130bps to 0.28% in 2022, then tumbled by 850bps to -8.22% in 2023, then spiked by 790bps to -0.32% in 2024.